Literature DB >> 16928254

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Nimish Vakil1, Sander V van Zanten, Peter Kahrilas, John Dent, Roger Jones.   

Abstract

OBJECTIVES: A globally acceptable definition and classification of gastroesophageal reflux disease (GERD) is desirable for research and clinical practice. The aim of this initiative was to develop a consensus definition and classification that would be useful for patients, physicians, and regulatory agencies.
METHODS: A modified Delphi process was employed to reach consensus using repeated iterative voting. A series of statements was developed by a working group of five experts after a systematic review of the literature in three databases (Embase, Cochrane trials register, Medline). Over a period of 2 yr, the statements were developed, modified, and approved through four rounds of voting. The voting group consisted of 44 experts from 18 countries. The final vote was conducted on a 6-point scale and consensus was defined a priori as agreement by two-thirds of the participants.
RESULTS: The level of agreement strengthened throughout the process with two-thirds of the participants agreeing with 86%, 88%, 94%, and 100% of statements at each vote, respectively. At the final vote, 94% of the final 51 statements were approved by 90% of the Consensus Group, and 90% of statements were accepted with strong agreement or minor reservation. GERD was defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. The disease was subclassified into esophageal and extraesophageal syndromes. Novel aspects of the new definition include a patient-centered approach that is independent of endoscopic findings, subclassification of the disease into discrete syndromes, and the recognition of laryngitis, cough, asthma, and dental erosions as possible GERD syndromes. It also proposes a new definition for suspected and proven Barrett's esophagus.
CONCLUSIONS: Evidence-based global consensus definitions are possible despite differences in terminology and language, prevalence, and manifestations of the disease in different countries. A global consensus definition for GERD may simplify disease management, allow collaborative research, and make studies more generalizable, assisting patients, physicians, and regulatory agencies.

Entities:  

Mesh:

Year:  2006        PMID: 16928254     DOI: 10.1111/j.1572-0241.2006.00630.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  902 in total

1.  Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation.

Authors:  Nimish Vakil; Börje Wernersson; Lis Ohlsson; John Dent
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Gastroesophageal reflux disease symptoms and dietary behaviors are significant correlates of short sleep duration in the general population: the Nagahama Study.

Authors:  Kimihiko Murase; Yasuharu Tabara; Yoshimitsu Takahashi; Shigeo Muro; Ryo Yamada; Kazuya Setoh; Takahisa Kawaguchi; Hiroshi Kadotani; Shinji Kosugi; Akihiro Sekine; Takeo Nakayama; Michiaki Mishima; Tsutomu Chiba; Kazuo Chin; Fumihiko Matsuda
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

3.  Combined Multichannel Intraluminal Impedance and pH Monitoring for Patients With Suspected Laryngopharyngeal Reflux: Is It Ready to Use?

Authors:  Justin C Y Wu
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

4.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

5.  [Diagnosis and therapy of atypical reflux symptoms when PPI therapy fails].

Authors:  M Bajbouj
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

6.  Hypopharyngeal multichannel intraluminal impedance leads to the promising outcome of antireflux surgery in Japanese population with laryngopharyngeal reflux symptoms.

Authors:  Takeshi Suzuki; Yosuke Seki; Yoshitaka Okamoto; Toshitaka Hoppo
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 7.  Evaluation of gastroesophageal reflux disease.

Authors:  Piero Marco Fisichella; Francisco Schlottmann; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

8.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: con.

Authors:  Lucía C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

9.  Bronchial reacutization and gastroesophageal reflux: is there a potential clinical correlation?

Authors:  Carlo Pomari; Luisa Mauroner; Simona Paiano; Luca Rosario Assante; Luca Bertolaccini; Giacomo Ruffo; Paride Mainardi; Paolo Bocus; Andrea Geccherle; Sergio Ivan Albanese; Stefano Ciaffoni
Journal:  Ann Transl Med       Date:  2016-08

10.  Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.

Authors:  Chun-Yan Niu; Yong-Li Zhou; Rong Yan; Ni-La Mu; Bao-Hua Gao; Fang-Xiong Wu; Jin-Yan Luo
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.